您搜索了: kemoterapiji (斯洛文尼亚语 - 英语)

uporaba pri kemoterapiji
use with chemotherapy

po kemoterapiji je treba
after chemotherapy, one 80 mg capsule

odrasli bolniki na kemoterapiji
adults on chemotherapy

z zdravljenjem začnite dan po kemoterapiji.
start on the day after your chemotherapy.

uporaba pri odraslih bolniki na kemoterapiji
use in adult patients receiving chemotherapy

po kemoterapiji morajo bolniki prejeti radioterapijo.
following chemotherapy, patients should receive radiotherapy.

po kemoterapiji morajo bolniki prejeti še kemoradioterapijo.
following chemotherapy, patients should receive chemoradiotherapy.

bolniki s presaditvijo kostnega mozga po kemoterapiji:
patients having a bone marrow transplant after chemotherapy:

zdravljenje nadaljujemo do 4 tedne po končani kemoterapiji.
the therapy should be continued up to 4 weeks after the end of chemotherapy.

drobnoceličnega pljučnega raka, ki se je ponovil po kemoterapiji.
mall cell lung cancer that has come back after chemotherapy.

ponovitve raka na jajčniku ali drobnoceličnega pljučnega raka po kemoterapiji.
ovarian cancer or small cell lung cancer that has come back after chemotherapy

bolniki, ki imajo po kemoterapiji presaditev kostnega mozga:
patients having a bone marrow transplant after chemotherapy:

zdravljenje je treba nadaljevati do 4 tedne po končani kemoterapiji.
therapy should be continued up to 4 weeks after the end of chemotherapy.

bolnik mora prvi odmerek grastofila prejeti 24 ur po citotoksični kemoterapiji.
the first dose of grastofil should be administered at least 24 hours after cytotoxic chemotherapy.

če imate v krvi manj kot 150.000 trombocitov/mm3 po kemoterapiji;
if the number of your blood platelets is fewer than 150,000/mm3 after chemotherapy

bolnik lahko prvi odmerek filgrastima prejme šele 24 ur po citotoksični kemoterapiji.
the first dose of filgrastim should not be administered less than 24 hours following cytotoxic chemotherapy.

zdravilo emend se je izkazalo za učinkovito tudi v prvih 24 urah po kemoterapiji.
emend was also shown to be effective in the first 24 hours after chemotherapy.

uporaba filgrastima samega ali po kemoterapiji izplavi krvotvorne matične celice v periferno kri.
use of filgrastim, either alone, or after chemotherapy, mobilises haematopoietic progenitor cells into peripheral blood.

eritrocitov so pri bolnikih na kemoterapiji raziskali v randomizirani, dvojno slepi mednarodni študiji.
is randomised, double-blind, multinational study.

grastofil za izplavljanje pbpc po mielosupresivni kemoterapiji: grastofil je treba dati s subkutano injekcijo.
grastofil for pbpc mobilisation after myelosuppressive chemotherapy: grastofil should be given by subcutaneous injection.